News
Bristol Myers Squibb and Bain Capital have formed a new independent biopharmaceutical company focused on developing new ...
AbbVie, Bristol Myers Squibb and Eli Lilly appear “relatively well-positioned,” while Novartis and Roche look more at risk, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results